About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6784 record(s)
Req # A-2023-000712
Adverse Drug Reaction (ADR). Report number: 001036984.Organization: Health Canada
September 2023
Req # A-2023-000770
Adverse Drug Reaction (ADR). Report number: 001036980.Organization: Health Canada
September 2023
Req # A-2023-000774
Adverse Drug Reaction (ADR). Report number: 001045682.Organization: Health Canada
September 2023
Req # A-2023-018
Please provide, in both official languages, a copy of the official languages timeline mentioned in OCOL’s tweet posted on May 9, 2023, at 1:21 p.m.Organization: Office of the Commissioner of Official Languages
September 2023
Req # A-2023-014
Please accept this request for records under the Access to Information Act. My request concerns documents related to the Official Languages Act (OLA). Specifically, I would like to receive electronic copies of the following records: • Any internal…Organization: Office of the Commissioner of Official Languages
September 2023
Req # A-2016-001311
The following documents: the Health Canada reviewer reports for RITUXAN SC related to review of Clinical, Clinical Pharmacology and Chemistry & Manufacturing information; and the Risk Management Plan (RMP) for RITUXAN SC.Organization: Health Canada
August 2023
Req # A-2018-000914
Information on adverse events related to medical devices. Hyaluronic acid or botulinum based products as of 2018-10-04. From 2015 - 2017.Organization: Health Canada
August 2023
Req # A-2018-001093
All information related to Natural Product Number (NPN) 80088599 provided, used and sent to and from Health Canada.Organization: Health Canada
August 2023
Req # A-2020-001730
A list of adverse reports that have resulted in deaths, regarding caffeinated energy drinks, taken from the consumption incident reports that have been received from Temporary Marketing Authorization Letter (TMAL) holders, in 2012, 2013 and 2016, as…Organization: Health Canada
August 2023
Req # A-2021-000697
The briefing binder prepared for the head of the Canadian Drug Agency Transition Office. March 1, 2021 - April 30, 2021.Organization: Health Canada
August 2023